New Research Explores How Type 1 Diabetes May Affect Brain Function in Children

A team of scientists conducted a detailed investigation into how Type 1 diabetes may affect thinking and memory in children. They found that a biological pathway involving three key components—TLR4, NF-κB, and FDX1—becomes activated when blood sugar is high and copper levels are abnormal. This pathway appears to trigger a process called cuproptosis, which damages brain cells.

The researchers also observed that this pathway disrupts the blood-brain barrier, a protective layer that normally prevents harmful substances from entering the brain. When this barrier breaks down, brain inflammation and cell damage can occur more easily.

The team used multiple approaches to test their theory. First, they grew brain cells in laboratory dishes under conditions mimicking high blood sugar and copper overload. Then they created a mouse model of Type 1 diabetes and used genetic techniques to block or reduce FDX1 and TLR4.

The researchers measured various markers of cell damage, tested how well the blood-brain barrier functioned, and assessed cognitive abilities in the mice. They also examined the direct interactions between the proteins involved in this pathway.

When researchers blocked TLR4 or reduced FDX1 in laboratory cells, the damage to brain cells and the blood-brain barrier decreased significantly. In mice with diabetes, the same interventions improved cognitive function and restored blood-brain barrier integrity.

The team confirmed that a regulatory protein called NF-κB directly controls how much FDX1 is produced, suggesting this is a coordinated biological response rather than a random event.

This exploratory research identifies a previously unknown mechanism that may help explain cognitive challenges some children with Type 1 diabetes experience. By pinpointing this pathway, scientists have identified potential targets for future drug development.

It is important to note that this is early-stage mechanistic research conducted in cells and animals. Further studies in humans will be necessary to confirm whether blocking this pathway can safely and effectively improve cognitive outcomes in children with Type 1 diabetes. Anyone concerned about cognitive symptoms should discuss them with their healthcare provider.

Source: Metabolic brain disease. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.